Cullinan Oncology Expands Leadership Team and Board of Directors with Appointments of Jeffrey Jones, M.D., MPH, MBA to Chief Medical Officer and Anne-Marie Martin Ph.D. to Board of Directors
The appointments of Dr. Jeff Jones as Chief Medical Officer and of Dr. Annie Martin to our Board of Directors expands our expertise within the oncology space and brings diverse perspectives to our leadership team, said Nadim Ahmed, Chief Executive Officer of Cullinan Oncology.
- The appointments of Dr. Jeff Jones as Chief Medical Officer and of Dr. Annie Martin to our Board of Directors expands our expertise within the oncology space and brings diverse perspectives to our leadership team, said Nadim Ahmed, Chief Executive Officer of Cullinan Oncology.
- Dr. Joness successful academic tenure and deep expertise in oncology drug development will be vital to our mission to create new standards-of-care for patients with cancer.
- I am thrilled to welcome Dr. Anne-Marie Martin to the Cullinan Oncology Board of Directors, where she will bring her experience and vision for oncology product development, said Tony Rosenberg, Chairman of the Board of Directors of Cullinan Oncology.
- Any forward-looking statement included in this press release speaks only as of the date on which it was made.